25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BIVI (Biovie Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Biovie Inc together

I guess you are interested in Biovie Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Biovie Inc’s Financial Insights
  • 📈 Technical Analysis (TA) – Biovie Inc’s Price Targets

I'm going to help you getting a better view of Biovie Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biovie Inc

I send you an email if I find something interesting about Biovie Inc.

1. Quick Overview

1.1. Quick analysis of Biovie Inc (30 sec.)










1.2. What can you expect buying and holding a share of Biovie Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.06
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
$1.17
Expected worth in 1 year
$1.33
How sure are you?
32.5%

+ What do you gain per year?

Total Gains per Share
$0.21
Return On Investment
23.0%

For what price can you sell your share?

Current Price per Share
$0.93
Expected price per share
$0.8177 - $1.45
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biovie Inc (5 min.)




Live pricePrice per Share (EOD)
$0.93
Intrinsic Value Per Share
$-12.75 - $8.58
Total Value Per Share
$-11.57 - $9.75

2.2. Growth of Biovie Inc (5 min.)




Is Biovie Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$21.8m$12.3m$6.5m34.5%

How much money is Biovie Inc making?

Current yearPrevious yearGrowGrow %
Making money-$4.7m-$9.2m$4.5m95.3%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biovie Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#504 / 881

Most Revenue
#744 / 881

Most Profit
#408 / 881

Most Efficient
#294 / 881
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biovie Inc?

Welcome investor! Biovie Inc's management wants to use your money to grow the business. In return you get a share of Biovie Inc.

First you should know what it really means to hold a share of Biovie Inc. And how you can make/lose money.

Speculation

The Price per Share of Biovie Inc is $0.925. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biovie Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biovie Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.17. Based on the TTM, the Book Value Change Per Share is $0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biovie Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.15-16.2%-0.26-27.7%-0.50-54.1%-0.45-48.3%-0.86-93.3%-0.46-49.8%
Usd Book Value Change Per Share-0.11-12.3%0.044.2%-0.04-4.1%0.055.8%0.077.0%0.033.2%
Usd Dividend Per Share0.022.2%0.011.5%0.000.0%0.000.5%0.4447.1%0.2426.1%
Usd Total Gains Per Share-0.09-10.1%0.055.8%-0.04-4.1%0.066.3%0.5054.1%0.2729.2%
Usd Price Per Share0.98-1.15-2.38-2.82-6.35-13.00-
Price to Earnings Ratio-1.63--1.16--1.16--1.47--4.57--299.77-
Price-to-Total Gains Ratio-10.49--7.26--108.14--39.42--27.36--1,114.33-
Price to Book Ratio0.83-1.11-4.31-4.10-9.39--349.92-
Price-to-Total Gains Ratio-10.49--7.26--108.14--39.42--27.36--1,114.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.925
Number of shares1081
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.010.44
Usd Book Value Change Per Share0.040.07
Usd Total Gains Per Share0.050.50
Gains per Quarter (1081 shares)57.57541.41
Gains per Year (1081 shares)230.282,165.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
16216822018842812156
212433745037695634322
318650568056538446488
4248673910753711258654
531084211409422140610820
63721010137011306168812986
74341178160013191196915152
84951347183015075225017318
95571515206016959253219484
106191683229018844281321650

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.046.00.02.1%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%6.014.00.030.0%10.030.00.025.0%11.036.00.023.4%
Dividend per Share3.00.01.075.0%3.00.09.025.0%6.00.014.030.0%8.00.032.020.0%8.00.039.017.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%8.012.00.040.0%13.027.00.032.5%14.033.00.029.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biovie Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1130.039-391%-0.038-67%0.053-313%0.065-274%0.029-486%
Book Value Per Share--1.1751.014+16%0.664+77%0.817+44%0.676+74%0.350+236%
Current Ratio--9.3157.944+17%1.997+366%4.849+92%10.101-8%5.994+55%
Debt To Asset Ratio--0.1150.227-49%0.575-80%0.478-76%0.929-88%0.954-88%
Debt To Equity Ratio--0.1300.335-61%1.496-91%1.377-91%0.980-87%1.202-89%
Dividend Per Share--0.0200.014+39%-+100%0.005+317%0.436-95%0.241-92%
Enterprise Value--38509030.00038750186.588-1%54872273.255-30%66124422.614-42%128848869.769-70%246276786.278-84%
Eps---0.150-0.256+71%-0.500+233%-0.447+197%-0.863+475%-0.460+207%
Ev To Ebitda Ratio---3.532-2.271-36%-1.661-53%-2.006-43%-4.828+37%-328.115+9191%
Free Cash Flow Per Share---0.067-0.235+248%-0.474+603%-0.393+482%-0.300+344%-0.157+133%
Free Cash Flow To Equity Per Share---0.067-0.097+44%-0.184+172%0.046-247%89175.260-100%44587.629-100%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--8.578----------
Intrinsic Value_10Y_min---12.750----------
Intrinsic Value_1Y_max---0.413----------
Intrinsic Value_1Y_min---1.530----------
Intrinsic Value_3Y_max---0.271----------
Intrinsic Value_3Y_min---4.406----------
Intrinsic Value_5Y_max--1.040----------
Intrinsic Value_5Y_min---7.050----------
Market Cap17177897.500-6%18199286.00021265772.838-14%44145339.505-59%52429883.531-65%117839541.169-85%241466269.578-92%
Net Profit Margin----0%-0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%-0%
Pb Ratio0.787-6%0.8341.113-25%4.312-81%4.103-80%9.391-91%-349.919+42050%
Pe Ratio-1.540+6%-1.632-1.162-29%-1.161-29%-1.471-10%-4.574+180%-299.768+18269%
Price Per Share0.925-6%0.9801.145-14%2.377-59%2.823-65%6.345-85%13.003-92%
Price To Free Cash Flow Ratio-3.426+6%-3.630-1.683-54%-1.121-69%-1.776-51%-21.070+480%-2313.932+63650%
Price To Total Gains Ratio-9.900+6%-10.488-7.258-31%-108.138+931%-39.416+276%-27.364+161%-1114.332+10524%
Quick Ratio--9.0927.830+16%2.206+312%4.932+84%10.118-10%5.970+52%
Return On Assets---0.113-0.196+73%-0.346+206%-0.307+172%-1.764+1461%-0.936+728%
Return On Equity---0.128-0.260+104%-0.902+606%-0.824+545%-1.862+1358%-1.169+815%
Total Gains Per Share---0.0930.053-275%-0.038-60%0.058-261%0.501-119%0.270-135%
Usd Book Value--21817945.00018828456.000+16%12326344.000+77%15169781.667+44%12545789.200+74%6493812.450+236%
Usd Book Value Change Per Share---0.1130.039-391%-0.038-67%0.053-313%0.065-274%0.029-486%
Usd Book Value Per Share--1.1751.014+16%0.664+77%0.817+44%0.676+74%0.350+236%
Usd Dividend Per Share--0.0200.014+39%-+100%0.005+317%0.436-95%0.241-92%
Usd Enterprise Value--38509030.00038750186.588-1%54872273.255-30%66124422.614-42%128848869.769-70%246276786.278-84%
Usd Eps---0.150-0.256+71%-0.500+233%-0.447+197%-0.863+475%-0.460+207%
Usd Free Cash Flow---1253503.000-4356069.250+248%-8806511.250+603%-7290061.667+482%-5570978.000+344%-2915224.650+133%
Usd Free Cash Flow Per Share---0.067-0.235+248%-0.474+603%-0.393+482%-0.300+344%-0.157+133%
Usd Free Cash Flow To Equity Per Share---0.067-0.097+44%-0.184+172%0.046-247%89175.260-100%44587.629-100%
Usd Market Cap17177897.500-6%18199286.00021265772.838-14%44145339.505-59%52429883.531-65%117839541.169-85%241466269.578-92%
Usd Price Per Share0.925-6%0.9801.145-14%2.377-59%2.823-65%6.345-85%13.003-92%
Usd Profit---2788000.000-4759500.000+71%-9294250.000+233%-8787333.333+215%-13642321.400+389%-6927289.775+148%
Usd Revenue----0%-0%-0%-0%-0%
Usd Total Gains Per Share---0.0930.053-275%-0.038-60%0.058-261%0.501-119%0.270-135%
 EOD+3 -5MRQTTM+23 -11YOY+24 -103Y+22 -125Y+17 -1810Y+18 -17

3.3 Fundamental Score

Let's check the fundamental score of Biovie Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.540
Price to Book Ratio (EOD)Between0-10.787
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than19.092
Current Ratio (MRQ)Greater than19.315
Debt to Asset Ratio (MRQ)Less than10.115
Debt to Equity Ratio (MRQ)Less than10.130
Return on Equity (MRQ)Greater than0.15-0.128
Return on Assets (MRQ)Greater than0.05-0.113
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Biovie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.980
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Biovie Inc

BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease. The company develops BIV201 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer's disease; and in Phase 2 clinical trial to treat Parkinson's disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada.

Fundamental data was last updated by Penke on 2025-06-19 00:52:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biovie Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--88.2%+88.2%
TTM--141.5%+141.5%
YOY--182.9%+182.9%
3Y--247.7%+247.7%
5Y--338.6%+338.6%
10Y--473.1%+473.1%
4.3.1.2. Return on Assets

Shows how efficient Biovie Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • -11.3% Return on Assets means that Biovie Inc generated $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biovie Inc:

  • The MRQ is -11.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -19.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.3%TTM-19.6%+8.3%
TTM-19.6%YOY-34.6%+15.0%
TTM-19.6%5Y-176.4%+156.9%
5Y-176.4%10Y-93.6%-82.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-11.3%-11.1%-0.2%
TTM-19.6%-11.2%-8.4%
YOY-34.6%-11.0%-23.6%
3Y-30.7%-11.6%-19.1%
5Y-176.4%-11.8%-164.6%
10Y-93.6%-13.6%-80.0%
4.3.1.3. Return on Equity

Shows how efficient Biovie Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • -12.8% Return on Equity means Biovie Inc generated $-0.13 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biovie Inc:

  • The MRQ is -12.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -26.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.8%TTM-26.0%+13.2%
TTM-26.0%YOY-90.2%+64.2%
TTM-26.0%5Y-186.2%+160.2%
5Y-186.2%10Y-116.9%-69.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.8%-12.8%+0.0%
TTM-26.0%-14.2%-11.8%
YOY-90.2%-14.1%-76.1%
3Y-82.4%-16.6%-65.8%
5Y-186.2%-17.3%-168.9%
10Y-116.9%-19.4%-97.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biovie Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biovie Inc is operating .

  • Measures how much profit Biovie Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biovie Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--227.4%+227.4%
TTM--253.9%+253.9%
YOY--201.7%+201.7%
3Y--214.9%+214.9%
5Y--339.9%+339.9%
10Y--444.7%+444.7%
4.3.2.2. Operating Ratio

Measures how efficient Biovie Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biovie Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.060-2.060
TTM-2.737-2.737
YOY-2.997-2.997
3Y-3.496-3.496
5Y-4.660-4.660
10Y-6.353-6.353
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biovie Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biovie Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.32 means the company has $9.32 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biovie Inc:

  • The MRQ is 9.315. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.944. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.315TTM7.944+1.372
TTM7.944YOY1.997+5.946
TTM7.9445Y10.101-2.158
5Y10.10110Y5.994+4.107
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.3153.670+5.645
TTM7.9443.745+4.199
YOY1.9974.121-2.124
3Y4.8494.623+0.226
5Y10.1015.733+4.368
10Y5.9946.143-0.149
4.4.3.2. Quick Ratio

Measures if Biovie Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Quick Ratio of 9.09 means the company can pay off $9.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biovie Inc:

  • The MRQ is 9.092. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.830. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ9.092TTM7.830+1.261
TTM7.830YOY2.206+5.624
TTM7.8305Y10.118-2.287
5Y10.11810Y5.970+4.148
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.0922.906+6.186
TTM7.8303.128+4.702
YOY2.2063.786-1.580
3Y4.9324.308+0.624
5Y10.1185.703+4.415
10Y5.9706.411-0.441
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biovie Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biovie Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biovie Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12 means that Biovie Inc assets are financed with 11.5% credit (debt) and the remaining percentage (100% - 11.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biovie Inc:

  • The MRQ is 0.115. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.227. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.115TTM0.227-0.111
TTM0.227YOY0.575-0.349
TTM0.2275Y0.929-0.702
5Y0.92910Y0.954-0.026
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1150.328-0.213
TTM0.2270.356-0.129
YOY0.5750.335+0.240
3Y0.4780.339+0.139
5Y0.9290.350+0.579
10Y0.9540.383+0.571
4.5.4.2. Debt to Equity Ratio

Measures if Biovie Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biovie Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 13.0% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biovie Inc:

  • The MRQ is 0.130. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.335. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.130TTM0.335-0.205
TTM0.335YOY1.496-1.161
TTM0.3355Y0.980-0.645
5Y0.98010Y1.202-0.222
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1300.384-0.254
TTM0.3350.436-0.101
YOY1.4960.413+1.083
3Y1.3770.447+0.930
5Y0.9800.464+0.516
10Y1.2020.512+0.690
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biovie Inc generates.

  • Above 15 is considered overpriced but always compare Biovie Inc to the Biotechnology industry mean.
  • A PE ratio of -1.63 means the investor is paying $-1.63 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biovie Inc:

  • The EOD is -1.540. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.632. Based on the earnings, the company is expensive. -2
  • The TTM is -1.162. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.540MRQ-1.632+0.092
MRQ-1.632TTM-1.162-0.470
TTM-1.162YOY-1.161-0.001
TTM-1.1625Y-4.574+3.412
5Y-4.57410Y-299.768+295.194
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.540-2.125+0.585
MRQ-1.632-2.027+0.395
TTM-1.162-2.541+1.379
YOY-1.161-3.670+2.509
3Y-1.471-3.716+2.245
5Y-4.574-6.057+1.483
10Y-299.768-6.591-293.177
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biovie Inc:

  • The EOD is -3.426. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.630. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.683. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.426MRQ-3.630+0.204
MRQ-3.630TTM-1.683-1.947
TTM-1.683YOY-1.121-0.562
TTM-1.6835Y-21.070+19.387
5Y-21.07010Y-2,313.932+2,292.862
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.426-3.030-0.396
MRQ-3.630-2.710-0.920
TTM-1.683-3.805+2.122
YOY-1.121-4.404+3.283
3Y-1.776-5.103+3.327
5Y-21.070-8.536-12.534
10Y-2,313.932-9.228-2,304.704
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biovie Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.83 means the investor is paying $0.83 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Biovie Inc:

  • The EOD is 0.787. Based on the equity, the company is cheap. +2
  • The MRQ is 0.834. Based on the equity, the company is cheap. +2
  • The TTM is 1.113. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.787MRQ0.834-0.047
MRQ0.834TTM1.113-0.278
TTM1.113YOY4.312-3.200
TTM1.1135Y9.391-8.278
5Y9.39110Y-349.919+359.310
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.7871.900-1.113
MRQ0.8341.861-1.027
TTM1.1132.162-1.049
YOY4.3122.465+1.847
3Y4.1032.527+1.576
5Y9.3913.682+5.709
10Y-349.9194.351-354.270
4.6.2. Total Gains per Share

2.4. Latest News of Biovie Inc

Does Biovie Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Biovie Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-06-27
18:48
New to The Street Announces the Broadcast of Show Number 675 This Saturday at 6:30 PM EST on Bloomberg Television Featuring: FLOKI, BioVie (NASDAQ: BIVI), Arrive AI ($ARAI), Health In Tech (NASDAQ HITRead
2025-06-24
22:05
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® CongressRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Biovie Inc.

4.8.1. Institutions holding Biovie Inc

Institutions are holding 5.614% of the shares of Biovie Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vanguard Group Inc2.88970536637446355494.4009
2025-03-31Geode Capital Management, LLC0.743201380231461511.8428
2025-03-31Goss Wealth Management LLC0.29130.00035410040000283.6879
2024-12-31UBS Group AG0.260204832748282107293.3333
2025-03-31SMH Capital Inc.0.21540.00614000000
2025-03-31HPM Partners LLC0.15790.0001293301210070.2263
2025-03-31Two Sigma Investments LLC0.11640.000121613-7100-24.7275
2025-03-31State Street Corp0.086301602200
2025-03-31Traynor Capital Management, Inc0.08620.001316000160000
2025-03-31Northern Trust Corp0.0824015300-1578-9.3494
2025-03-31DRIVE WEALTH MANAGEMENT, LLC0.08080.003515000-45000-75
2025-03-31Bank of Montreal0.07013000-37000-74
2025-03-31BMO Capital Markets Corp.0.07013000-37000-74
2025-03-31Royal Bank of Canada0.0607011280278032.7059
2025-03-31HRT FINANCIAL LLC0.05870.000110901109010
2025-03-31Tower Research Capital LLC0.02910.000254123456176.6871
2025-03-31Morgan Stanley - Brokerage Accounts0.026204862-20264-80.6495
2025-03-31SBI Securities Co Ltd0.01490.00012759109365.6062
2025-03-31Atlantic Trust Group, LLC0.00960178200
2024-12-31Wells Fargo & Co0.008301545995180.9091
Total 5.35730.0118994893+448635+45.1%

4.9.2. Funds holding Biovie Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-04-30Vanguard Total Stock Mkt Idx Inv2.565047633800
2025-04-30Belfund SICAV Belinvest Equity A USD Acc0.53850.159610000000
2025-04-30Vanguard Institutional Extnd Mkt Idx Tr0.39240.0001728711313621.9905
2025-04-30Fidelity Extended Market Index0.38650.000271783-686-0.9466
2025-04-30Fidelity Total Market Index0.129302400800
2025-04-30Fidelity Series Total Market Index0.097701814010646.231
2025-03-31NT Ext Equity Mkt Idx Fd - L0.07630.00021416800
2025-03-31Northern Trust Extended Eq Market Idx0.07630.00021416800
2025-04-30Spartan Extended Market Index Pool F0.07360.0002136736865.2822
2025-04-30Spartan Total Market Index Pool G0.04370811700
2025-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.01830.00023403270.7998
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T40.01820.0003337633760
2024-12-31NT Ext Eq Mkt Indx Fd DC Lend T30.01820.0003337633760
2025-04-30Fidelity Nasdaq Composite Index0.01240229500
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.00560104300
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.00440812-15-1.8138
2025-04-30Vanguard U.S. Eq Idx £ Acc0.003056400
2025-03-31BNYM Mellon SL Market Completion UC10.00160.0001292-1-0.3413
2025-05-31State St US Extended Mkt Indx NL Cl C0.0005010000
2025-03-31Northern Trust Wilshire 50000.000508900
Total 4.4620.1614828616+20963+2.5%

5.3. Insider Transactions

Insiders are holding 13.27% of the shares of Biovie Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-30Cuong V DoBUY100001.78
2023-09-05Steve GorlinSELL85603.05
2023-08-22Richard J BermanSELL108053.5
2023-06-07Richard J BermanSELL59845.81
2023-05-22Richard J BermanSELL50006.5
2023-03-27Richard J BermanSELL33718.52
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets24,660
Total Liabilities2,842
Total Stockholder Equity21,818
 As reported
Total Liabilities 2,842
Total Stockholder Equity+ 21,818
Total Assets = 24,660

Assets

Total Assets24,660
Total Current Assets23,722
Long-term Assets939
Total Current Assets
Cash And Cash Equivalents 23,152
Other Current Assets 570
Total Current Assets  (as reported)23,722
Total Current Assets  (calculated)23,722
+/-0
Long-term Assets
Property Plant Equipment 357
Goodwill 346
Intangible Assets 236
Long-term Assets  (as reported)939
Long-term Assets  (calculated)939
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,547
Long-term Liabilities296
Total Stockholder Equity21,818
Total Current Liabilities
Short-term Debt 71
Other Current Liabilities 2,476
Total Current Liabilities  (as reported)2,547
Total Current Liabilities  (calculated)2,547
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt296
Long-term Liabilities  (as reported)296
Long-term Liabilities  (calculated)296
+/-0
Total Stockholder Equity
Common Stock7
Retained Earnings -348,655
Other Stockholders Equity 370,466
Total Stockholder Equity (as reported)21,818
Total Stockholder Equity (calculated)21,818
+/-0
Other
Capital Stock7
Cash and Short Term Investments 23,152
Common Stock Shares Outstanding 18,507
Liabilities and Stockholders Equity 24,660
Net Debt -22,786
Net Invested Capital 21,818
Net Working Capital 21,175
Property Plant and Equipment Gross 357
Short Long Term Debt Total 366



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-30
> Total Assets 
0
446
407
360
333
318
293
282
269
266
250
233
2,719
2,540
2,478
2,452
2,364
2,323
2,246
2,215
2,175
4,208
3,645
2,964
2,574
2,608
2,340
2,309
2,084
14,861
13,460
12,893
6,047
21,978
31,873
26,188
20,115
22,859
47,192
45,183
35,105
23,760
21,490
31,773
25,208
21,238
25,694
24,660
24,66025,69421,23825,20831,77321,49023,76035,10545,18347,19222,85920,11526,18831,87321,9786,04712,89313,46014,8612,0842,3092,3402,6082,5742,9643,6454,2082,1752,2152,2462,3232,3642,4522,4782,5402,7192332502662692822933183333604074460
   > Total Current Assets 
0
446
407
360
333
318
293
282
269
266
250
233
131
9
5
35
5
22
2
28
46
2,136
1,630
1,007
674
765
554
581
413
13,248
11,903
11,394
4,605
20,594
30,547
24,792
18,780
21,590
45,990
44,047
34,041
22,764
20,562
30,540
24,048
20,151
24,681
23,722
23,72224,68120,15124,04830,54020,56222,76434,04144,04745,99021,59018,78024,79230,54720,5944,60511,39411,90313,2484135815547656741,0071,6302,1364628222535591312332502662692822933183333604074460
       Cash And Cash Equivalents 
0
446
407
345
333
318
288
279
267
266
250
233
124
9
5
35
5
22
2
28
46
2,136
1,630
972
340
249
3
4
37
13,196
11,876
11,351
4,512
20,488
30,392
24,507
18,642
21,231
45,749
31,276
19,461
21,215
20,227
30,350
23,844
20,023
24,406
23,152
23,15224,40620,02323,84430,35020,22721,21519,46131,27645,74921,23118,64224,50730,39220,4884,51211,35111,87613,19637432493409721,6302,1364628222535591242332502662672792883183333454074460
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
12,521
14,478
0
0
0
0
0
0
0
000000014,47812,521000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
14
0
0
5
4
2
1
0
0
7
0
0
0
0
0
0
0
0
0
0
35
334
516
551
577
376
52
27
43
187
106
155
285
276
718
483
250
103
1,549
335
190
204
128
276
570
5702761282041903351,54910325048371827628515510618743275237657755151633435000000000070012450014000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,588
2,531
2,474
2,416
2,359
2,302
2,244
2,187
0
2,072
2,015
1,958
1,900
1,843
1,786
1,728
1,671
1,614
1,556
1,499
1,442
1,384
1,327
1,397
1,335
1,269
1,202
1,135
1,064
996
929
1,233
1,160
1,087
1,013
939
9391,0131,0871,1601,2339299961,0641,1351,2021,2691,3351,3971,3271,3841,4421,4991,5561,6141,6711,7281,7861,8431,9001,9582,0152,07202,1872,2442,3022,3592,4162,4742,5312,588000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
2,588
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
127
118
109
100
91
81
71
60
422
407
391
374
357
3573743914074226071819110010911812700000000000000000000002,588000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346
346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346346000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
2,243
2,185
2,128
2,071
2,013
1,956
1,899
1,841
1,784
1,727
1,669
1,612
1,555
1,497
1,440
1,383
1,325
1,268
1,211
1,153
1,096
1,039
981
924
866
809
752
694
637
580
522
465
408
350
293
236
2362933504084655225806376947528098669249811,0391,0961,1531,2111,2681,3251,3831,4401,4971,5551,6121,6691,7271,7841,8411,8991,9562,0132,0712,1282,1852,243000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5
5
5
0
0
0
0
0
0
0
0
0
000000000555000000000000000000000000000000000000
> Total Liabilities 
0
9
17
3
161
204
247
283
324
373
404
445
803
961
1,151
979
1,207
1,241
1,455
1,660
2,064
183
105
179
443
11,329
4,384
4,654
23,583
266
385
1,491
996
1,744
15,808
16,234
16,444
16,898
21,124
23,464
19,764
16,212
13,999
12,847
9,702
7,171
1,772
2,842
2,8421,7727,1719,70212,84713,99916,21219,76423,46421,12416,89816,44416,23415,8081,7449961,49138526623,5834,6544,38411,3294431791051832,0641,6601,4551,2411,2079791,15196180344540437332428324720416131790
   > Total Current Liabilities 
0
9
17
3
161
204
247
283
324
373
404
445
803
961
1,151
403
631
665
879
1,084
1,238
183
105
179
443
11,329
4,384
4,654
23,520
203
322
1,428
996
1,260
4,358
4,317
4,169
4,096
7,797
16,004
14,495
13,212
13,981
12,481
9,352
6,838
1,457
2,547
2,5471,4576,8389,35212,48113,98113,21214,49516,0047,7974,0964,1694,3174,3581,2609961,42832220323,5204,6544,38411,3294431791051831,2381,0848796656314031,15196180344540437332428324720416131790
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
10
0
21
10
35
10
576
25
0
0
0
0
0
2
52
473
849
0
0
0
0
0
0
59
78
81
84
6,434
9,150
9,385
10,244
8,050
5,762
3,384
67
71
71673,3845,7628,05010,2449,3859,1506,43484817859000000849473522000002557610351021010000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
21
10
347
10
576
601
0
0
0
0
0
2
52
473
849
0
0
0
0
0
0
0
0
0
0
6,391
9,105
9,339
10,195
7,993
5,701
3,320
0
0
003,3205,7017,99310,1959,3399,1056,39100000000008494735220000060157610347102100000000000000
       Accounts payable 
0
9
0
3
0
2
5
1
1
9
1
1
294
389
506
330
471
468
629
746
884
183
105
179
443
684
1,085
1,300
1,259
203
322
1,428
996
679
1,663
1,206
2
3
3,245
5
3
3
4
4,410
3,587
0
0
0
0003,5874,41043353,245321,2061,6636799961,4283222031,2591,3001,085684443179105183884746629468471330506389294119115203090
       Other Current Liabilities 
0
0
17
0
161
202
242
283
323
363
404
444
500
572
625
63
125
188
250
313
0
354
0
0
0
10,643
3,247
2,881
21,412
0
0
0
996
581
2,695
3,053
4,089
4,012
4,468
9,570
5,341
3,824
3,734
21
4
3,454
1,390
2,476
2,4761,3903,4544213,7343,8245,3419,5704,4684,0124,0893,0532,69558199600021,4122,8813,24710,64300035403132501881256362557250044440436332328324220216101700
   > Long-term Liabilities 
0
9
0
3
0
2
5
1
0
9
1
1
0
389
517
576
576
576
576
576
0
826
105
179
443
2
1,137
473
63
63
63
63
0
484
11,450
11,916
12,274
12,802
13,327
7,460
5,270
3,000
18
366
350
333
315
296
296315333350366183,0005,2707,46013,32712,80212,27411,91611,4504840636363634731,137244317910582605765765765765765173890119015203090
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
63
63
0
0
0
0
12,139
12,725
13,261
0
0
0
0
0
0
0
0
0
00000000013,26112,72512,13900006363000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
576
576
576
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
484
339
194
48
0
0
0
0
0
0
0
0
0
0
0
0000000000048194339484000000000000000576576576000000000000000
> Total Stockholder Equity
0
437
390
357
171
115
46
-1
-54
-107
-155
-211
1,916
1,578
1,327
1,473
1,157
1,082
791
555
111
4,025
3,541
2,785
2,131
-8,721
-2,044
-2,344
-21,499
14,596
13,075
11,402
5,050
20,234
16,065
9,955
3,671
5,961
26,068
21,718
15,340
7,548
7,491
18,926
15,506
14,067
23,923
21,818
21,81823,92314,06715,50618,9267,4917,54815,34021,71826,0685,9613,6719,95516,06520,2345,05011,40213,07514,596-21,499-2,344-2,044-8,7212,1312,7853,5414,0251115557911,0821,1571,4731,3271,5781,916-211-155-107-54-1461151713573904370
   Common Stock
0
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
9
10
10
32
32
32
51
65
1
1
1
1
1
1
2
2
2
2
2
3
3
4
4
4
4
6
6
6
7
7
7766644443322222111111655132323210109999999999999999990
   Retained Earnings Total Equity000000000-277,073-261,386-250,9700000-93,353-90,360000000000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
-12
-11
-9
-7
0
-3
-1
0
0
0
0
-10
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
104,755
0
0
0
0
0
0
0
17
177
0
0
0
0
0
0
0
0000000177170000000104,755000000000000000-100000-1-30-7-9-11-120000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
103,434
104,754
0
0
0
0
254,638
267,344
303,137
0
0
0
0
0
0
0
0
0
000000000303,137267,344254,6380000104,754103,434000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
500
500
514
502
504
506
514
510
514
514
514
2,912
2,925
3,032
3,366
3,483
4,071
4,282
4,739
0
9,251
9,267
9,360
9,342
19,397
19,472
19,539
19,539
101,897
103,434
104,754
229,934
250,658
251,903
252,833
254,638
267,344
303,137
313,812
316,386
319,480
327,825
348,212
349,733
352,770
369,782
370,466
370,466369,782352,770349,733348,212327,825319,480316,386313,812303,137267,344254,638252,833251,903250,658229,934104,754103,434101,89719,53919,53919,47219,3979,3429,3609,2679,25104,7394,2824,0713,4833,3663,0322,9252,9125145145145105145065045025145005000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-229
Gross Profit-229-229
 
Operating Income (+$)
Gross Profit-229
Operating Expense-31,950
Operating Income-32,180-32,179
 
Operating Expense (+$)
Research Development23,100
Selling General Administrative8,850
Selling And Marketing Expenses0
Operating Expense31,95031,950
 
Net Interest Income (+$)
Interest Income1,137
Interest Expense-2,894
Other Finance Cost-0
Net Interest Income-1,757
 
Pretax Income (+$)
Operating Income-32,180
Net Interest Income-1,757
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-32,121-32,239
EBIT - interestExpense = -35,073
-32,350
-29,227
Interest Expense2,894
Earnings Before Interest and Taxes (EBIT)-32,179-29,227
Earnings Before Interest and Taxes (EBITDA)-31,950
 
After tax Income (+$)
Income Before Tax-32,121
Tax Provision-0
Net Income From Continuing Ops-32,121-32,121
Net Income-32,121
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses32,180
Total Other Income/Expenses Net591,757
 

Technical Analysis of Biovie Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biovie Inc. The general trend of Biovie Inc is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biovie Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Biovie Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biovie Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.21 < 1.32 < 1.45.

The bearish price targets are: 0.99 > 0.9829 > 0.8177.

Know someone who trades $BIVI? Share this with them.👇

Biovie Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biovie Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biovie Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biovie Inc.

Biovie Inc Daily Moving Average Convergence/Divergence (MACD) ChartBiovie Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biovie Inc. The current adx is .

Biovie Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biovie Inc.

Biovie Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biovie Inc.

Biovie Inc Daily Relative Strength Index (RSI) ChartBiovie Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biovie Inc.

Biovie Inc Daily Stochastic Oscillator ChartBiovie Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biovie Inc.

Biovie Inc Daily Commodity Channel Index (CCI) ChartBiovie Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biovie Inc.

Biovie Inc Daily Chande Momentum Oscillator (CMO) ChartBiovie Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biovie Inc.

Biovie Inc Daily Williams %R ChartBiovie Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biovie Inc.

Biovie Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biovie Inc.

Biovie Inc Daily Average True Range (ATR) ChartBiovie Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biovie Inc.

Biovie Inc Daily On-Balance Volume (OBV) ChartBiovie Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biovie Inc.

Biovie Inc Daily Money Flow Index (MFI) ChartBiovie Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biovie Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-03STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-05MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-10CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-03-18STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-11MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-05-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-22WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-10SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside

6.3. Candlestick Patterns

Biovie Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biovie Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.980
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biovie Inc with someone you think should read this too:
  • Are you bullish or bearish on Biovie Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biovie Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biovie Inc

I send you an email if I find something interesting about Biovie Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Biovie Inc.

Receive notifications about Biovie Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.